SEARCH

SEARCH BY CITATION

References

  • Adkins CE, Pillai GV, Kerby J, Bonnert TP, Haldon C, McKernan RM, Gonzalez JE, Oades K, Whiting PJ, Simpson PB. (2001) α4β3δ GABAA receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J Biol Chem276:3893438939.
  • Akaike N, Hattori K, Inomata N, Oomura Y. (1985) γ-Aminobutyric-acid- and pentobarbitone-gated chloride currents in internally perfused frog sensory neurones. J Physiol360:367386.
  • Akk G, Steinbach JH. (2000) Activation and block of recombinant GABAA receptors by pentobarbitone: a single-channel study. Br J Pharmacol130:249258.
  • Akk G, Li P, Bracamontes J, Wang M, Steinbach JH. (2011) Pharmacology of structural changes at the GABAA receptor transmitter binding site. Br J Pharmacol162:840850.
  • Amin J. (1999) A single hydrophobic residue confers barbiturate sensitivity to γ-aminobutyric acid type C receptor. Mol Pharmacol55:411423.
  • Amin J, Weiss DS. (1993) GABAA receptor needs two homologous domains of the β-subunit for activation by GABA but not by pentobarbital. Nature366:565569.
  • Bachmann A, Mueller S, Kopp K, Brueggemann A, Suessbrich H, Gerlach U, Busch AE. (2002) Inhibition of cardiac potassium currents by pentobarbital. Naunyn Schmiedebergs Arch Pharmacol365:2937.
  • Baudoux S, Empson RM, Richards CD. (2003) Pentobarbitone modulates calcium transients in axons and synaptic boutons of hippocampal CA1 neurons. Br J Pharmacol140:971979.
  • Bethmann K, Fritschy JM, Brandt C, Löscher W. (2008) Antiepileptic drug resistant rats differ from drug responsive rats in GABAA-receptor subunit expression in a model of temporal lobe epilepsy. Neurobiol Dis31:169187.
  • Blaustein MP. (1968) Barbiturates block sodium and potassium conductance increases in voltage-clamped lobster axons. J Gen Physiol51:293307.
  • Blaustein MP. (1976) Barbiturates block calcium uptake by stimulated and potassium-depolarized rat sympathetic ganglia. J Pharmacol Exp Ther196:8086.
  • Blaustein MP, Ector AC. (1975) Barbiturate inhibition of calcium uptake by depolarized nerve terminals in vitro. Mol Pharmacol11:369378.
  • Bocquet N, Nury H, Baaden M, Le Poupon C, Changeux J-P, Delarue M, Corringer PJ. (2009) X-ray structure of a pentameric ligand-gated ion channel in an apparentlyopen conformation. Nature457:111114.
  • Brandt C, Volk HA, Löscher W. (2004) Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Epilepsia45:14881497.
  • Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. (1998) Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy. Nat Med4:11661172.
  • Büch HP, Schneider-Affeld F, Rummel W. (1973) Stereochemical dependence of pharmacological activity in a series of optically active N-methylated barbiturates. Naunyn Schmiedebergs Arch Pharmacol277:191198.
  • Bureau MH, Olsen RW. (1993) GABAA receptor subtypes: ligand binding heterogeneity demonstrated by photoaffinity labeling and autoradiography. J Neurochem61:14791491.
  • Cestari IN, Uchida I, Li L, Burt D, Yang J. (1996) The agonistic action of pentobarbital on GABAAβ-subunit homomeric receptors. NeuroReport7:943947.
  • Chen ZW, Olsen RW. (2007) GABAA receptor associated proteins: a key factor regulating GABAA receptor function. J Neurochem100:279294.
  • Chen Q, Cheng MH, Xu Y, Tang P. (2010) Anesthetic binding in a pentameric ligand-gated ion channel: GLIC. Biophys J99:18011809.
  • Chiara DC, Dostalova Z, Jayakar SS, Zhou X, Miller KW, Cohen JB. (2012) Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue. Biochemistry51:836847.
  • Cote IL, Zbicz KL, Wilson WA. (1978) Barbiturate-induced slow outward currents in Aplysia neurones. Nature274:594596.
  • Cozanitis DA. (2004) One hundred years of barbiturates and their saint. J R Soc Med97:594598.
  • Downes H, Perry RS, Ostlund RE, Karler R. (1970) A study of the excitatory effects of barbiturates. J Pharmacol Exp Ther175:692699.
  • Drafts BC, Fisher JL. (2006) Identification of structures within GABAA receptor α subunits that regulate the agonist action of pentobarbital. J Pharmacol Exp Ther318:10941101.
  • Dunwiddie TV, Worth TS, Olsen RW. (1986) Facilitation of recurrent inhibition in rat hippocampus by barbiturate and related nonbarbiturate depressant drugs. J Pharmacol Exp Ther238:564575.
  • Eadie MJ, Kwan P (2008) Phenobarbital and other barbiturates (Chapter 153). In Engel J Jr, Pedley TA (Eds) Epilepsy, a comprehensive textbook. 2nd ed. Vol. II. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, pp. 15991607.
  • Eaton M, Lim YB, Bracamontes J, Steinbach JH, Akk G. (2012) Agonist-specific conformational changes in the structure of the α1-γ2 subunit interface of the GABAA receptor. Mol Pharmacol82:255263.
  • Eccles JC, Schmidt R, Willis WD. (1963) Pharmacological studies on presynaptic inhibition. J Physiol168:500530.
  • Erstad BL, Cotugno CL. (1995) Management of alcohol withdrawal. Am J Health Syst Pharm52:697709.
  • Feng HJ, Macdonald RL. (2010) Barbiturates require the N terminus and first transmembrane domain of the δ subunit for enhancement of α1β3δ GABAA receptor currents. J Biol Chem285:2361423621.
  • Feng HJ, Bianchi MT, Macdonald RL. (2004) Pentobarbital differentially modulates α1β3δ and α1β3γ2L GABAA receptor currents. Mol Pharmacol66:9881003.
  • ffrench-Mullen JM, Barker JL, Rogawski MA. (1993) Calcium current block by (−)-pentobarbital, phenobarbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl current. J Neurosci13:32113221.
  • Frandsen A, Quistorff B, Schousboe A. (1990) Phenobarbital protects cerebral cortex neurones against toxicity induced by kainate but not by other excitatory amino acids. Neurosci Lett111:233238.
  • Gilat E, Rubinstein I, Binah O. (1987) Effect of sodium pentobarbital on the transmembrane action potential and the slow inward current of guinea pig ventricular myocytes. J Cardiovasc Pharmacol10:485488.
  • Haley TJ, Gidley JT. (1970) Pharmacological comparison of R(+), S(−) and racemic secobarbital in mice. Eur J Pharmacol9:358361.
  • Hanek AP, Lester HA, Dougherty DA. (2010) Photochemical proteolysis of an unstructured linker of the GABAAR extracellular domain prevents GABA but not pentobarbital activation. Mol Pharmacol78:2935.
  • Harrison NL, Krasowski MD, Harris RA. (2000) Alcohol and general anesthetic actions on the GABAA receptor. In Martin DL, Olsen RW (Eds) GABA in the nervous system: the view at fifty years. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 167289.
  • Heinbecker P, Bartley SH. (1940) Action of ether and nembutal on the nervous system. J Neurophysiol3:219236.
  • Hjort AM, De Beer EJ, Fassett DW. (1938) The antianesthetic effects of some convulsants in the albino mouse. J Pharmacol Exp Ther63:421431.
  • Ho IK, Harris RA. (1981) Mechanism of action of barbiturates. Annu Rev Pharmacol Toxicol21:83111.
  • Holmes GL, Khazipov R, Ben Ari Y. (2002) New concepts in neonatal seizures. NeuroReport13:A3A8.
  • Huguenard JR, Wilson WA. (1985) Barbiturate-induced alterations in the kinetic parameters of slow outward current in Aplysia giant neurons. J Pharmacol Exp Ther234:821829.
  • Jones AW, Dooley JD, Murphy JR. (1950) Treatment of choice in barbiturate poisoning; series of twenty-nine cases of barbiturate poisoning treated with pentylenetetrazole (Metrazol) and supportive therapy. J Am Med Assoc143:884888.
  • Jurna I. (1985) Electrophysiological effects of antiepileptic drugs. In Frey H-H, Janz D (Eds) Antiepileptic drugs. Springer, Berlin, pp. 611658.
  • Kahle KT, Staley KJ. (2008) The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus25:18.
  • Keeser E, Keeser J. (1927) Über die Lokalization des Veronals, der Phenyläthyl- und Diallylbarbitursäure im Gehirn (Beitrag zum Schlafproblem). Arch Exp Pathol Pharmakol125:251256.
  • Kitayama M, Hirota K, Kudo M, Kudo T, Ishihara H, Matsuki A. (2002) Inhibitory effects of intravenous anaesthetic agents on K+-evoked glutamate release from rat cerebrocortical slices. Involvement of voltage-sensitive Ca2+ channels and GABAA receptors. Naunyn Schmiedebergs Arch Pharmacol366:246253.
  • Ko GY, Brown-Croyts LM, Teyler TJ. (1997) The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus. Brain Res Bull42:297302.
  • Kokate TG, Svensson BE, Rogawski MA. (1994) Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther270:12231229.
  • Koppanyi T, Dille JM. (1935) Remarks on the distribution of barbiturates in the brain. J Pharmacol Exp Ther54:8486.
  • Kumar S, Fleming RL, Morrow AL. (2004) Ethanol regulation of gamma-aminobutyric acid A receptors: genomic and nongenomic mechanisms. Pharmacol Ther101:211226.
  • Kwan P, Brodie MJ. (2004) Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia45:11411149.
  • Larrabee MG, Posternak JM. (1952) Selective action of anesthetics on synapses and axons in mammalian sympathetic ganglia. J Neurophysiol15:91114.
  • Leeb-Lundberg F, Snowman A, Olsen RW. (1980) Barbiturate receptor sites are coupled to benzodiazepine receptors. Proc Natl Acad Sci USA77:74687472.
  • Li GD, Chiara DC, Sawyer GW, Husain SS, Olsen RW, Cohen JB. (2006) Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J Neurosci26:1159911605.
  • Lin LH, Wang LH. (1996) Region-specific changes in GABAA receptor delta subunit mRNA level by tolerance to and withdrawal from pentobarbital. Neurosci Lett202:149152.
  • Lingamaneni R, Hemmings HC Jr. (2003) Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABAA receptors. Br J Anaesth90:199211.
  • Lopez-Munoz F, Ucha-Udabe R, Alamo C. (2005) The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat1:329343.
  • Löscher W, Puskarjov M, Kaila K. (2012) Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments. Neuropharmacology June 15 [Epub ahead of print].
  • Lundy JS, Osterberg AE. (1929) Review of the literature on the derivatives of barbituric Acid. Proc Staff Meet Mayo Clin4:385416.
  • Macdonald RL, Barker JL. (1977) Phenobarbital enhances GABA-mediated postsynaptic inhibition in cultured mammalian neurons. Trans Am Neurol Assoc102:139140.
  • Macdonald RL, Barker JL. (1978) Different actions of anticonvulsant and anesthetic barbiturates revealed by use of cultured mammalian neurons. Science200:775777.
  • Macdonald RL, Barker JL. (1979) Anticonvulsant and anesthetic barbiturates: different postsynaptic actions in cultured mammalian neurons. Neurology29:432447.
  • Macdonald RL, Olsen RW. (1994) GABAA receptor channels. Annu Rev Neurosci17:569602.
  • Macdonald RL, Twyman RE. (1991) Biophysical properties and regulation of GABAA receptor channels. Semin Neurosci3:219235.
  • Macdonald RL, Mclean MJ, Skerritt JH. (1985) Anticonvulsant drug mechanisms of action. Fed Proc44:26342639.
  • Maloney AH, Fitch RH, Tatum AL. (1931) Picrotoxin as an antidote in acute poisoning by the shorter acting barbiturates. J Pharmacol Exp Ther41:465482.
  • Mathers DA, Barker JL. (1980) (−)Pentobarbital opens ion channels of long duration in cultured mouse spinal neurons. Science209:507509.
  • Mathers DA, Wan X, Puil E. (2007) Barbiturate activation and modulation of GABAA receptors in neocortex. Neuropharmacology52:11601168.
  • Mathews GC, Bolos-Sy AM, Covey DF, Rothman SM, Ferrendelli JA. (1996) Physiological comparison of α-ethyl-α-methyl-γ-thiobutyrolactone with benzodiazepine and barbiturate modulators of GABAA receptors. Neuropharmacology35:123136.
  • Mercado J, Czajkowski C. (2006) Charged residues in the α1 and β2 pre-M1 regions involved in GABAA receptor activation. J Neurosci26:20312040.
  • Mercado J, Czajkowski C. (2008) γ-Aminobutyric acid (GABA) and pentobarbital induce different conformational rearrangements in the GABAA receptor α1 and β2 pre-M1 regions. J Biol Chem283:1525015257.
  • Miller PS, Smart TG. (2010) Binding, activation and modulation of Cys-loop receptors. Trends Pharmacol Sci31:161174.
  • Muroi Y, Theusch CM, Czajkowski C, Jackson MB. (2009) Distinct structural changes in the GABAA receptor elicited by pentobarbital and GABA. Biophys J96:499509.
  • Narahashi T, Frazier DT, Deguchi T, Cleaves CA, Ernau MC. (1971) The active form of pentobarbital in squid giant axons. J Pharmacol Exp Ther177:2533.
  • Nardou R, Yamamoto S, Bhar A, Burnashev N, Ben Ari Y, Khalilov I. (2011) Phenobarbital but not diazepam reduces AMPA/kainate receptor mediated currents and exerts opposite actions on initial seizures in the neonatal rat hippocampus. Front Cell Neurosci5:16.
  • Nattel S, Wang ZG, Matthews C. (1990) Direct electrophysiological actions of pentobarbital at concentrations achieved during general anesthesia. Am J Physiol259:H1743H1751.
  • Nicoll RA. (1972) The effects of anaesthetics on synaptic excitation and inhibition in the olfactory bulb. J Physiol223:803814.
  • Nicoll RA. (1975a) Pentobarbital: action on frog motoneurons. Brain Res96:119123.
  • Nicoll RA. (1975b) Presynaptic action of barbiturates in the frog spinal cord. Proc Natl Acad Sci USA72:14601463.
  • Nicoll RA. (1978) Selective actions of barbiturates on synaptic transmission. In Lipton MA, Di-Mascio KF, Killam KF (Eds) Psychopharmacology: a generation of progress. Raven, New York, pp. 13371348.
  • Nicoll RA, Eccles JC, Oshima T, Rubia F. (1975) Prolongation of hippocampal inhibitory postsynaptic potentials by barbiturates. Nature258:625627.
  • Olsen RW. (2002) Phenobarbital and other barbiturates. In Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds) Antiepileptic drugs. 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 489495.
  • Olsen RW, Li GD. (2011) GABAA receptors as molecular targets of general anesthetics: identification of binding sites provides clues to allosteric modulation. Can J Anaesth58:206215.
  • Pistis M, Belelli D, McGurk K, Peters JA, Lambert JJ. (1999) Complementary regulation of anaesthetic activation of human (α6β3γ2L) and Drosophila (RDL) GABA receptors by a single amino acid residue. J Physiol515:318.
  • Porter RJ, Dhir A, Macdonald RL, Rogawski MA. (2012) Mechanisms of action of antiseizure drugs. In Stefan H, Theodore WH (Eds) Handbook of clinical neurology, 3rd series, Vol. 108, Epilepsy Part II: Treatment. Elsevier, Amsterdam, pp. 663682.
  • Prichard JW. (1980) Phenobarbital: proposed mechanisms of antiepileptic action. Adv Neurol27:553562.
  • Prichard JW, Ransom BR. (1995) Phenobarbital. Mechanisms of action. In Levy RH, Mattson RH, Meldrum BS (Eds) Antiepileptic drugs. 4th ed. Raven Press, New York, pp. 359369.
  • Raines A, Blake GJ, Richardson B, Gilbert MB. (1979) Differential selectivity of several barbiturates on experimental seizures and neurotoxicity in the mouse. Epilepsia20:105113.
  • Ransom BR, Barker JL. (1975) Pentobarbital modulates transmitter effects on mouse spinal neurones grown in tissue culture. Nature254:703705.
  • Rho JM, Donevan SD, Rogawski MA. (1996) Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. J Physiol497:509522.
  • Rogawski MA, Löscher W. (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci5:553564.
  • Rogawski MA, Porter RJ. (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev42:223286.
  • Rüsch D, Zhong H, Forman SA. (2004) Gating allosterism at a single class of etomidate sites on α1β2γ2L GABAA receptors accounts for both direct activation and agonist modulation. J Biol Chem279:2098220992.
  • Sabelli HC, Diamond BI, May J, Havdala HS. (1977) Differential interactions of phenobarbital and pentobarbital with beta-adrenergic mechanisms in vitro and in vivo. Exp Neurol54:453466.
  • Sancar F, Czajkowski C. (2011) Allosteric modulators induce distinct movements at the GABA-binding site interface of the GABA-A receptor. Neuropharmacology60:520528.
  • Schober A, Sokolova E, Gingrich KJ. (2010) Pentobarbital inhibition of human recombinant α1A P/Q-type voltage-gated calcium channels involves slow, open channel block. Br J Pharmacol161:365383.
  • Schoepfle GM. (1957) Pentothal block of single nerve fibers and subsequent revival by means of anodal polarization. Fed Proc16:114.
  • Scholfield CN. (1978) A barbiturate induced intensification of the inhibitory potential in slices of guinea-pig olfactory cortex. J Physiol275:559566.
  • Schulz DW, Macdonald RL. (1981) Barbiturate enhancement of GABA-mediated inhibition and activation of chloride ion conductance: correlation with anticonvulsant and anesthetic actions. Brain Res209:177188.
  • Serafini R, Bracamontes J, Steinbach JH. (2000) Structural domains of the human GABAA receptor β3 subunit involved in the actions of pentobarbital. J Physiol524.3:649676.
  • Shu HJ, Bracamontes J, Taylor A, Wu K, Eaton MM, Akk G, Manion B, Evers AS, Krishnan K, Covey DF, Zorumski CF, Steinbach JH, Mennerick S. (2012) Characteristics of concatemeric GABAA receptors containing α4/δ subunits expressed in Xenopus oocytes. Br J Pharmacol165:22282243.
  • Sieghart W, Ramerstorfer J, Sarto-Jackson I, Varagic Z, Ernst M. (2012) A novel GABAA receptor pharmacology: drugs interacting with the α(+) β(−) interface. Br J Pharmacol166:476485.
  • Takeuchi H. (1968) [Modifications by phenobarbital of the electric properties of neurons with a stable membrane potential (giant A neuron of Aplysia)]. C R Seances Soc Biol Fil162:488490.
  • Tatum AL. (1939) The present status of the barbiturate problem. Physiol Rev19:472502.
  • Tatum AL. (1940) The pharmacology of barbiturates. Annu Rev Physiol2:359386.
  • Thompson SA, Whiting PJ, Wafford KA. (1996) Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br J Pharmacol117:521527.
  • Toman JE. (1949) The neuropharmacology of antiepileptics. Electroencephalogr Clin Neurophysiol1:3344.
  • Toman JE. (1952) Neuropharmacology of peripheral nerve. Pharmacol Rev4:168218.
  • Tonner PH, Miller KW. (1995) Molecular sites of general anaesthetic action on acetylcholine receptors. Eur J Anaesthesiol12:2130.
  • Vazquez AJ, Diamond BI, Sabelli HC. (1975) Differential effects of phenobarbital and pentobarbital on isolated nervous tissue. Epilepsia16:601608.
  • Volk HA, Arabadzisz D, Fritschy JM, Brandt C, Bethman K, Löscher W. (2006) Antiepileptic drug resistant rats differ from drug responsive rats in hippocampal neurodegeneration and GABAA-receptor ligand-binding in a model of temporal lobe epilepsy. Neurobiol Dis21:633646.
  • Wan X, Mathers DA, Puil E. (2003) Pentobarbital modulates intrinsic and GABA-receptor conductances in thalamocortical inhibition. Neuroscience121:947958.
  • Wartenberg HC, Wartenberg JP, Urban BW. (2001) Human cardiac sodium channels are affected by pentobarbital. Eur J Anaesthesiol18:306313.
  • Weber M, Motin L, Gaul S, Beker F, Fink RH, Adams DJ. (2005) Intravenous anaesthetics inhibit nicotinic acetylcholine receptor-mediated currents and Ca2+ transients in rat intracardiac ganglion neurons. Br J Pharmacol144:98107.
  • Werz MA, Macdonald RL. (1985) Barbiturates decrease voltage-dependent calcium conductance of mouse neurons in dissociated cell culture. Mol Pharmacol28:269277.
  • Yang JS, Olsen RW. (1987) γ-Aminobutyric acid receptor-regulated 36Cl flux in mouse cortical slices. J Pharmacol Exp Ther241:677685.
  • Zeller A, Arras M, Jurd R, Rudolph U. (2007) Identification of a molecular target mediating the general anesthetic actions of pentobarbital. Mol Pharmacol71:852859.
  • Zipf K, Windachua WA, Kokoschka F. (1937) Zur Wirkung von Cardiazol, Coramin, Hexeton, Strychnin und Ikoral gegenüber Narkotica. Arch Exp Pathol Pharmakol185:113124.